International Journal of Research and Reports in Hematology

  • About
    • About the Journal
    • Submissions & Author Guideline
    • Accepted Papers
    • Editorial Policy
    • Editorial Board Members
    • Reviewers
    • Propose a Special Issue
    • Reprints
    • Subscription
    • Membership
    • Publication Ethics and Malpractice Statement
    • Digital Archiving Policy
    • Contact
  • Archives
  • Indexing
  • Publication Charge
  • Submission
  • Testimonials
  • Announcements
Advanced Search
  1. Home
  2. Archives
  3. 2018 - Volume 1 [Issue 2]
  4. Original Research Article

Submit Manuscript


Subscription



  • Home Page
  • Author Guidelines
  • Editorial Board Member
  • Editorial Policy
  • Propose a Special Issue
  • Membership

An Open Label, Single Arm Multi-Centric Study to Assess the Safety and Efficacy of Sodium Feredetate (Fedate Syrup) within 21 Days in Patients with Iron Deficiency Anemia in Ivory Coast

  • Saurav Deka
  • Isidore Bli B. Die
  • Oura N’Guessan

International Journal of Research and Reports in Hematology, Page 1-7

Published: 11 January 2019

  • View Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract


Introduction: Iron deficiency anemia is a common disease prevalent mostly in developing countries Replenishing iron stores via oral route supplementation takes longer time, however for safety reasons it is considered as the most convenient route. There is always search of better oral iron supplement which can replenish the iron deficiency at short duration of time.


Objectives: A post-marketing surveillance study to assess the safety and efficacy of Fedate syrup (Sodium Feredetate) within 21 days in clinical practice.


Materials and Methods: A total 40 patients visiting 2 gynaecologists, who had a hemoglobin (Hb) level of < 10 gm/dl, and had a body mass index (BMI) of < 24 kg /m2 were included in the study. All patients were prescribed either 10-15 ml Fedate syrup once or twice a day. Clinical effectiveness was assessed over a period of 21 days. Treatment response was recorded as responders or non-responders based on a minimum 1 gm/dl increase in Hb levels.


Results: A total of 33 patients (82.5%) responded to the treatment within 21 days as compared to 7 patients (17.5%) who did not respond to the treatment. There was significant difference in global efficacy and assessment of tolerability which was recorded on a scale of poor to excellent. The drug was tolerated well in all patients responding either as “good” or “excellent” to the treatment. Global efficacy was “poor” in 6 patients (15%) and “excellent” in 20 (50%). The paired student’s T-test score for increase in hemoglobin from baseline to 21st day was 5.4995 (P<0.0001).


Conclusions: We conclude that Sodium Feredetate is an effective compound as Fedate syrup in improving the symptoms of anemia in majority of the patients.


Keywords:
  • Iron deficiency anemia
  • Sodium Feredetate
  • hemoglobin
  • and oral iron.
  • Full Article - PDF
  • Review History

How to Cite

Deka, S., Die, I. B. B., & N’Guessan, O. (2019). An Open Label, Single Arm Multi-Centric Study to Assess the Safety and Efficacy of Sodium Feredetate (Fedate Syrup) within 21 Days in Patients with Iron Deficiency Anemia in Ivory Coast. International Journal of Research and Reports in Hematology, 1(2), 1-7. Retrieved from https://journalijr2h.com/index.php/IJR2H/article/view/29821
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Abstract View: 1285 times
    PDF Download: 1519 times

Download Statistics

  • Linkedin
  • Twitter
  • Facebook
  • WhatsApp
  • Telegram
Make a Submission / Login
Information
  • For Readers
  • For Authors
  • For Librarians
Current Issue
  • Atom logo
  • RSS2 logo
  • RSS1 logo


© Copyright 2010-Till Date, International Journal of Research and Reports in Hematology. All rights reserved.